CAMP Q4 2025 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$348,000-46.6% YoY

Gross Profit

-$24,000-6.9% margin

Operating Income

-$13M-3671.3% margin

Net Income

-$40M-11575.9% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

-56.2%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$118M

Total Liabilities

$70M

Stockholders' Equity

$48M

Cash & Equivalents

$110M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$348,000	$652,000	-46.6%
Gross Profit	-$24,000	$652,000	-103.7%
Operating Income	-$13M	-$14M	+9.0%
Net Income	-$40M	-$13M	-203.4%